These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 29474964)
1. Hypoxia-specific therapeutic agents delivery nanotheranostics: A sequential strategy for ultrasound mediated on-demand tritherapies and imaging of cancer. Feng Q; Li Y; Yang X; Zhang W; Hao Y; Zhang H; Hou L; Zhang Z J Control Release; 2018 Apr; 275():192-200. PubMed ID: 29474964 [TBL] [Abstract][Full Text] [Related]
2. Erythrocyte-Camouflaged Mesoporous Titanium Dioxide Nanoplatform for an Ultrasound-Mediated Sequential Therapies of Breast Cancer. Li Q; Lin B; Li Y; Lu N Int J Nanomedicine; 2021; 16():3875-3887. PubMed ID: 34135582 [TBL] [Abstract][Full Text] [Related]
3. Cancer cell membrane-coated C-TiO Ning S; Dai X; Tang W; Guo Q; Lyu M; Zhu D; Zhang W; Qian H; Yao X; Wang X Acta Biomater; 2022 Oct; 152():562-574. PubMed ID: 36067874 [TBL] [Abstract][Full Text] [Related]
4. Cancer Cell Membrane-Biomimetic Nanoplatform for Enhanced Sonodynamic Therapy on Breast Cancer via Autophagy Regulation Strategy. Feng Q; Yang X; Hao Y; Wang N; Feng X; Hou L; Zhang Z ACS Appl Mater Interfaces; 2019 Sep; 11(36):32729-32738. PubMed ID: 31415145 [TBL] [Abstract][Full Text] [Related]
5. Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer. Chen J; Luo H; Liu Y; Zhang W; Li H; Luo T; Zhang K; Zhao Y; Liu J ACS Nano; 2017 Dec; 11(12):12849-12862. PubMed ID: 29236476 [TBL] [Abstract][Full Text] [Related]
6. Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics. Huang J; Liu F; Han X; Zhang L; Hu Z; Jiang Q; Wang Z; Ran H; Wang D; Li P Theranostics; 2018; 8(22):6178-6194. PubMed ID: 30613291 [No Abstract] [Full Text] [Related]
7. pH/Ultrasound Dual-Responsive Gas Generator for Ultrasound Imaging-Guided Therapeutic Inertial Cavitation and Sonodynamic Therapy. Feng Q; Zhang W; Yang X; Li Y; Hao Y; Zhang H; Hou L; Zhang Z Adv Healthc Mater; 2018 Mar; 7(5):. PubMed ID: 29141114 [TBL] [Abstract][Full Text] [Related]
8. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies. Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277 [TBL] [Abstract][Full Text] [Related]
9. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy. Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899 [TBL] [Abstract][Full Text] [Related]
10. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223 [TBL] [Abstract][Full Text] [Related]
11. Radiation-responsive scintillating nanotheranostics for reduced hypoxic radioresistance under ROS/NO-mediated tumor microenvironment regulation. Dou Y; Liu Y; Zhao F; Guo Y; Li X; Wu M; Chang J; Yu C Theranostics; 2018; 8(21):5870-5889. PubMed ID: 30613268 [TBL] [Abstract][Full Text] [Related]
12. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy. Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383 [TBL] [Abstract][Full Text] [Related]
13. An Ultrasound-Triggered Nanoplatform for Synergistic Sonodynamic-Nitric Oxide Therapy. Wang L; Tian Y; Lai K; Liu Y; Liu Y; Mou J; Yang S; Wu H ACS Biomater Sci Eng; 2023 Feb; 9(2):797-808. PubMed ID: 36662809 [TBL] [Abstract][Full Text] [Related]
14. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics. Pan X; Wang H; Wang S; Sun X; Wang L; Wang W; Shen H; Liu H Sci China Life Sci; 2018 Apr; 61(4):415-426. PubMed ID: 29666990 [TBL] [Abstract][Full Text] [Related]
15. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy. Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102 [TBL] [Abstract][Full Text] [Related]
16. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation. Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760 [No Abstract] [Full Text] [Related]
17. Reactive Oxygen Species-Manipulated Drug Release from a Smart Envelope-Type Mesoporous Titanium Nanovehicle for Tumor Sonodynamic-Chemotherapy. Shi J; Chen Z; Wang B; Wang L; Lu T; Zhang Z ACS Appl Mater Interfaces; 2015 Dec; 7(51):28554-65. PubMed ID: 26587885 [TBL] [Abstract][Full Text] [Related]
18. Core-shell structured Fe3O4@TiO2-doxorubicin nanoparticles for targeted chemo-sonodynamic therapy of cancer. Shen S; Wu L; Liu J; Xie M; Shen H; Qi X; Yan Y; Ge Y; Jin Y Int J Pharm; 2015; 486(1-2):380-8. PubMed ID: 25841570 [TBL] [Abstract][Full Text] [Related]
19. Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy. Zhang N; Tan Y; Yan L; Zhang C; Xu M; Guo H; Zhuang B; Zhou L; Xie X Int J Nanomedicine; 2020; 15():5687-5700. PubMed ID: 32821097 [TBL] [Abstract][Full Text] [Related]
20. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation. Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]